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n December 2019, coronavirus disease 2019 (COVID-19),
an infectious disease caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) caused an international outbreak. The World Health Organization designated
this as a global pandemic on March 11, 2020, with over 200
countries affected worldwide. As of April 24, 2020, there were
2 790 986 patients with confirmed COVID-19 and 195 775
deaths worldwide, with the United States, Spain, Italy, France,
Germany, United Kingdom, Turkey, and Iran surpassing China
in the number of confirmed cases.1 In a consecutive series of
221 patients with confirmed COVID-19 admitted to a hospital
in Wuhan, China, acute ischemic stroke occurred in 11(5%) of
patients with a broad range of stroke subtypes.2 These patients
with stroke were older, more likely to have cardiovascular
risk factors, presenting with severe COVID-19 with multiple
organ involvement. Of note, presence of COVID-19 in these
patients does not imply that COVID-19 was the mechanism
leading to the patient’s stroke.
Shortages of Personal Protective Equipment (PPE) such
as N95 masks, facial shields, hand sanitizer, and cleansing
wipes have presented a major challenge in the allocation of
resources, as healthcare workers are frontline in the treatment

of these patients.3 Redeployment of clinical staff, nursing,
stroke and neurocritical care specialists to care for patients
with COVID-19 may create staffing shortages for dedicated
stroke care.
In an effort to mitigate the spread of COVID-19 to neuroscience healthcare workers, their patients, and their families,
and to optimize allocation of healthcare resources, we present
a modified algorithm to acute ischemic large vessel occlusion
stroke workflow in the era of the COVID-19 pandemic. This
guidance statement is based on shared best practices,4–6 consensus among academic and nonacademic practicing vascular
and interventional neurologists, literature review, and would
be adapted to the available resources of a local institution. The
patients with acute stroke are a vulnerable group to address
because these patients often come emergently from the community with little information. Radical changes are felt to be
necessary to optimize the safety of the providing team and our
patients, limit unnecessary tests, conserve PPE resources and
mechanical ventilator usage. This document divides into the
following: prehospital phase to the Emergency Department
(ED), prethrombectomy procedure, thrombectomy intraprocedure, and postreperfusion therapy phases (Table).
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Table. Guidance Summary for Large Vessel Occlusion Stroke in the Era of
COVID-19

Prehospital care
 Every patient with acute stroke (direct presenting to ED or in transfer)
should be triaged for symptoms and signs of COVID-19, including
potential contact.
 If there is a positive screen, this patient should wear a surgical mask and
be placed in isolation in a negative pressure room. If telecommunication
(phone±video) is available, it should be utilized. Identify the minimum
number of providers needed to care for the patient and wear PPE for any
patient contact.
 If there is a positive pulmonary symptom, consider noncontrast chest CT
at the same time as head and neck CT/CTA, provided this addition does
not incur >5 min delay. Note, if a patient is received in transfer from
another hospital or has already returned from radiology, chest CT should
not be performed before reperfusion therapies such as intravenous
thrombolysis nor thrombectomy.*
 A direct to angiography suite approach should be considered for stable
patients with stroke symptoms onset within 24 h, who are transferred
from other hospitals with time from last neuroimaging within 2 h and
ASPECTS ≥7.

Table.

Continued

 Have an observer watch provider don their gown and protective gear.
 Double gloves, a face mask, N-95 mask in COVID-19 suspect or positive
patients, shoe covers, and protective gear should be utilized.
 Hanging lead shields and standing lead shields should be used as
another layer of protection.
 Have hand sanitizer near the doors entering or exiting angiography or
recovery rooms.
 Plan an area to place the phone and pager of the proceduralist in the
control room.
Thrombectomy intraprocedure
 Keep staff to a minimum in the procedure (ie, 1 nurse, 1 technologist,
1 physician) to minimize exposure to COVID-19, and conserve
protective gear.
 Tape the doors to the angio suite room or with a sign so other people do
not enter inadvertently without protective gear.
 Discuss with primary team on additional blood tests the proceduralist can
draw off the sheath for COVID-19 and stroke workup (ie, ABG, CBC, Chem7,
LFTs, BNP, CK in young patients, Procalcitonin, cholesterol panel, HbA1c, etc)

Consent and health care proxy

 Have an observer watch providers doff their gown and gear.

 If the patient is not consentable, the legally authorized representative
(LAR) should consent for the patient. Two physician emergency consent
should be obtained if the LAR is not available.

 Ensure any trash is completely inside the trash bag.

 If the patient is consentable, perform verbal procedural consent with
witness. Include consent for general anesthesia.
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 If the patient is consentable, perform verbal healthcare proxy consent
with a witness.
Airway preparation
 The anesthesiologist should be alerted early of a patient with COVID-19
or suspect patient.
 Consider conscious sedation as first line if the patient is stable.
 Discuss whether there should be dedicated COVID-19 glidescope ready
in the angio suite in case the patient deteriorates.
 In a patient who is considered at risk for airway deterioration (ie,
orthopnea, tachypnea, or respiratory distress lying flat, high oxygen
requirement), inability to protect airway, active vomiting, agitated or
uncooperative, then early and controlled intubation is preferred.
 Discuss where the patient gets intubated if they need intubation
(ie, negative pressure room before coming to angio suite, or on the
angio table).
 Review in advance whether anesthesia presence is required in the room
or as needed for intubation or hemodynamic issues.
Thrombectomy room preparation before patient arrival
 Remove all unnecessary objects or items in the angio suite to minimize
need for periop team for cleaning post procedure (ie, lead aprons that
will not be utilized).
 Cover countertop items with plastic or remove them.
 Prepare all procedural elements in the room before patient arrival (ie,
medications, devices, cover detector, pedals with plastic, bags, etc) to
minimize time of the patient in the room, protect room equipment, and
prevent breaking scrub.
 Cover the cabinets of the supply closet before the patient enters the
room.
(Continued )

Neurological exam, vital sign, and access site checks post-thrombectomy
 Nonintubated, stable patients can be moved to a step-down unit with
appropriate nursing expertise in the setting of a shortage or anticipated
shortage of critical care beds.
 Postprocedure neurological exam and access site checks should be
performed by one provider and minimized to conserve PPE.
 When the patient is handed off to the receiving team, have the gowned
provider check the patient’s neurological exam, vital signs, and/or access
site before doffing their PPE. This can count as the 15- or 30-minute
check post-procedure depending on the time that has elapsed.
 If telecommunication/video can serve as a continuous monitor of the
patient, it should be.
 Otherwise, consider another neurological exam, vital sign, and/or
access site check 15 or 30 min after hand-off, and then every hour×2.
Thereafter, these combined checks can be q4h.
 The frequency of combined neurological, vital sign, and/or access site
checks should be adjusted depending on patient status (less if they
are intubated and sedated), the patient’s hemodynamic stability, and
concern for access site bleeding.
Postthrombectomy therapy
 There should be a 30-minute delay before perioperative clean staff clean
the angio suite room to allow the room to air out.
 The patient should be extubated in a negative pressure room once they
meet criteria.
 Postpone or delay all but absolutely necessary tests for the patient until
they rule out for COVID-19 (to protect staff, protective gear, prevent virus
trafficking).
 Communication with family is important as visitation rights may be
restricted. This can take place by telephone.
 When rounding on the inpatient wards, patients on contact or droplet
precaution should be seen at the end of rounds to avoid unintentional
viral spread to patients not on precaution, assuming that these patients
are medically stable.
(Continued )
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Continued

 If a provider develops symptoms of cough, fever, or shortness of
breath, they should seek testing and potential quarantine based on
local protocols.
Psychosocial intervention
 When appropriate, an evaluation of a patient’s mental health is important
to alleviate the psychosocial impact of the COVID-19 pandemic for a
patient in isolation with a new or recurrent diagnosis of stroke
 Debrief to learn from each other and perform quality improvement.
Postacute care
 Consider testing for COVID-19 if not already done in a patient being
transitioned to a postacute care facility to facilitate transitions of care.
ABG indicates arterial blood gas; BNP, B-type natriuretic peptide;
CBC, complete blood count; CK, creatine kinase; COVID-19, coronavirus
disease 2019; CTA, computed tomography angiography; ED, emergency
department; HbA1c, hemoglobin A1c; LFT, liver function test; and PPE,
personal protective equipment.
*See accompanying text in manuscript.

Prehospital and ED Care of Acute Large Vessel
Occlusion
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Adhering to existing local protocols, all patients (including
stroke) presenting to the ED or as interhospital transfers, are
screened for signs and symptoms of COVID-19. Any patient
who is COVID-19 positive or screen positive should be managed under local protocols to ensure both patient and staff
safety. Use of remote telestroke technology should be considered to obtain history and perform neurological examination,
if available. During a Code Stroke, coordination between team
members with predefined assigned roles (ie, one team member
in PPE with patient, another member talks to family over telephone, looks at images, laboratories, and orders thrombolysis
or medications) will help reduce staff exposure while maintaining quality care.
If there is positive screening for COVID-19, this patient
should wear a surgical mask and immediately be placed in a
negative pressure room in the ED if one is available.7 A test
for COVID-19 should be considered if the patient meets local
criteria for investigation. If a patient or their family is unable
to provide corroborative history, then a surgical mask should
be placed on this patient, the patient tested for COVID-19 and
precautions in place.
Team members evaluating acute stroke code patients in
person should be kept to a minimum (ie, one physician, one nurse)
and wear appropriate PPE including full sleeved gown, surgical
mask, eye protection (face shield or equivalent), and gloves.8
Personal protection should be escalated to N95 mask, hair cap,
double gloves, shoe covers in the setting of contact with patient
with confirmed COVID-19 and/or aerosolizing events such as
coughing, sneezing, nebulizer treatment, suctioning, nasogastric
tube placement, bag mask ventilation, CPR, and intubation.
A dedicated computed tomography (CT) scan room for
patients with COVID-19 should be established if multiple CT
rooms are available. If there are positive pulmonary symptoms, consider low-dose chest CT at the same time as the performance of CT head with CT angiography head and neck,
as long as the addition of the chest CT does not incur >5-minute delay to treatment. CT chest may facilitate COVID-19

diagnosis.9,10 However, decision-making to test a patient for
COVID-19 or about need for quarantine should be based on
local protocols. Of note, if a patient had a head CT/CT angiography at an outside hospital or has returned to the ER from
head CT/CT angiography, repeat CT to evaluate for chest pathology should not be performed before reperfusion therapy
or thrombectomy.
If CT perfusion is part of an institution’s protocol for selection of thrombectomy patients in the late window, it should
be performed at the same time as CT head and CT angiography. Recent data suggest that in the 6- to 24-hour time
window, clinical core mismatch by Alberta Stroke Program
Early CT Score (ASPECTS) (6–10) on noncontrast CT overlaps with clinical core mismatch by CT perfusion or MRI
using DAWN criteria11 in nearly 80% of cases.12 Given the
overwhelming benefit of thrombectomy noted in DAWN, it is
reasonable to assume that meaningful benefit from thrombectomy exists when imaging criteria defining the clinical core
mismatch in DAWN are substituted by ASPECTS scores on
noncontrast CT. Lack of CT perfusion or MRI capabilities in
a resource constrained environment should not be a deterrent
from thrombectomy in the 6- to 24-hour time window.
As it would minimize exposure to emergency department
and CT suite personnel, a direct to the angiography suite
approach should be considered for stable transferred patients
with stroke symptoms onset within 24 hours, particularly if
the time from the outside hospital imaging to arrival is <2
hours and CT ASPECTS is ≥7. This approach has been shown
to safely reduce times to reperfusion and may lead to better
functional outcomes.12,13

Airway Preparation
The anesthesiologist should be alerted early of a COVID-19 or
suspect patient. Local policies for intubation and general anesthesia versus conscious sedation differ at different centers. If
appropriate, consider conscious sedation as first-line to protect
anesthesiologists from exposure and to protect our patients from
unnecessary intubation as well as conserving mechanical ventilator resources.14,15 Converting a patient from conscious sedation to general anesthesia in the middle of the procedure in the
angiography suite should be avoided due to high risk of aerosolization in a positive pressure room. In a patient who is considered at risk for airway deterioration (ie, orthopnea, tachypnea,
or respiratory distress lying flat, high oxygen requirement), unable to protect their airway, agitation, uncooperative, or actively
vomiting, then early and controlled intubation is preferred. An
aerosol box can be used as a cover as an additional measure
of PPE protection during intubation.16 High-flow oxygen, bagvalve mask, and noninvasive positive pressure ventilation are
not recommended due to the concern for aerosolization of virus.
Rapid sequence intubation may be the preferred course.
There should be a discussion regarding where the patient
gets intubated if it is seen necessary (ie, in a negative pressure
room in the ED, operating theater, ICU versus angiography
suite). If no negative pressure room is immediately available,
the treatment plans should continue forward. Any breach in
the ventilator tubing should be avoided, which can be a source
for aerosolization and exposure to health care workers.
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If the decision is for conscious sedation, consideration
for a dedicated COVID-19 glidescope or video laryngoscopy
can be prepared in the angiography suite in case the patient
deteriorates. Advance discussion on whether the anesthesiologist is required in the angiography suite during the case
should be reviewed or as needed for intubation or hemodynamic support. If the patient requires intubation in the angiography suite, all nonessential persons should leave the room.
Following intubation, any person entering the room should be
in full PPE because of concern for residual aerosolization of
virus post intubation.

Procedural Consent and Health Care Proxy
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If the patient is unable to consent, a legally authorized representative should consent for the patient. If no contact can be
reached, 2-physician emergency consent may be obtained or
the proper documentation for the treatment risks and benefits
and the failed attempts to contact family can be made in the
medical record as per local institutional protocols.
If the patient is consentable, it is preferable to have a
patient verbally authorize staff to sign the consent form for
them. Inanimate objects such as pens and tablets can become
a vehicle of spread for COVID-19. This may be considered
appropriate in the setting of the COVID-19 pandemic; however, local standards should be adhered to. The staff assistant
would sign the patient’s name and document themselves as
witness in the presence of the patient. If the patient declines
directed signature, they should be provided a new pen and
sign the form.
At the same time, as the procedural consent, consent for
general anesthesia should be obtained.
In a consentable patient, designation of a healthcare
proxy consent should be conducted with a staff witness in
the event the patient loses the ability to provide informed
consent. This step may be important because rehabilitation
or long-term care facilities may require this document to
accept a candidate patient.

Preprocedure Room Preparation
The charge nurse and technologist should be alerted as soon
as there is a suspected or patient with confirmed COVID-19
patient and room preparation dependent on the institution. If
there are multiple angiography rooms available, a COVID19 room can be designated. The procedure room should be
cleared of any unnecessary items (ie, lead aprons that will
not be utilized) to minimize the need of perioperative staff
cleaning post-procedure. Countertop items should be covered with plastic or removed. The detectors on the angiography suite, foot pedal, and lead shields should be covered
in plastic or an equivalent. The hanging lead shields and
standing lead shields can be used as another layer of protection for the proceduralist.
The table, medications, and procedural preparation should
be made in advance as much as possible to improve speed to
reperfusion, limit the time the patient is in the suite, limit the
need to break in and out of the room to retrieve materials or
break scrub. The cabinets of the supply materials should be
covered before the patient comes in the room.

There should be a designated space for the proceduralist
phone and/or pager in the control room and communication
maintained with the proceduralist via intercom or walkie-talkie if there is an urgent call.
If circumstances allow, it is optimal to have an observer
ensure proper donning of gown and protective gear by each
member in the procedure room per institutional protocol. This
should include double gloving, wearing a face mask that covers the eyes, N95 mask in COVID-19 suspected patients, and
wearing shoe covers.
There should be hand sanitizer stations near the doors entering or exiting the angio suite room as well as in patient
recovery areas.

Thrombectomy Intraprocedure
In the procedure, staff should be kept to a minimum (ie, 1
nurse, 1 technologist, 1 physician) to limit provider exposure
and limit use of protective gear. Door entry to the angiography suite should be taped with a sign to prevent people
from entering inadvertently without protective gear. Most
angiography suites are positive pressure rooms. Opening any
doors to the angiography suite should be minimized once the
patient is in the room to prevent movement of the virus to
adjacent spaces.
In the control room, consider limiting the number of
people to maintain a 6-foot distance between team members.
These persons should wear a mask if the door between the
angio suite and control room is opened because the angiography suite is likely to be a positive pressure room and can
contaminate the adjacent rooms.
Negative or even fluid balance should be maintained given
the risk for pulmonary edema in patients with COVID-19.
Heparinized bag flushes should be monitored closely to ensure
inadvertent excess fluid administration. Blood loss should be
minimized given concurrent national shortages of blood.
After the procedure is completed, discuss with the admitting team and draw blood tests from the sheath that may be necessary for COVID-19 and stroke workup if not already done (ie,
arterial blood gas, complete blood count, Chem 7, creatine kinase, and hypercoagulable panel in younger patients, B-type natriuretic peptide, troponin, hemoglobin A1c, cholesterol panel,
etc) to limit the need for additional blood draws and exposures.
Cone-beam head CT (Xper or Dyna) should be considered while the patient is on the angiography suite table postprocedure to obviate the need for travel to CT, with the caveat
of limited quality.
Ensure any trash is completely inside the trash bag.
If the room is big enough, place red tape on the floor of
the angio suite 6 feet from the patient’s bed. This would be
the area outside of which a provider would doff their gown.
Again, an observer to watch team members doff off their
gown and gear can be helpful to identify potential contamination or technique mistakes, if available.

Neurological, Vital Signs, and/or Access Site
Checks Postreperfusion Therapy
Nonintubated, stable patients can be moved to a step-down
unit with appropriate nursing expertise in the setting of
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a shortage or anticipated shortage of critical care beds.6
Repatriation or transfer of a patient post-thrombectomy
from a comprehensive stroke center to a primary stroke
center with appropriate physician and nursing expertise can
be considered in the setting of hospitals overwhelmed by a
shortage of ventilators or critical care beds while maintaining thrombectomy access. Communication between transferring and receiving teams, advance notification to patient
families of repatriation is important to maintain optimal
patient care.
Postprocedure or postthrombolytic neurological exam
and/or access site checks should be combined and performed
by one person and the frequency minimized to conserve
PPE. When the patient is handed off to the receiving team,
have the provider check the neurological exam, vitals, and/or
access site before doffing their gown. This can qualify as the
15- or 30-minute check post-procedure or post thrombolytic,
depending on the time that has elapsed.
Video can be utilized as a continuing monitor of the
patient’s neurological exam and/or access site. Otherwise,
consider another combined exam, vital sign, and/or access site
check 15 or 30 minutes after hand-off, and then every hour×2.
Thereafter, if the patient has remained stable, the intervals for
the combined checks can be spread to q4h. The frequency of
checks should be adjusted depending on the patient’s status
(less if they are intubated and sedated), hemodynamic stability, perceived risk of hemorrhagic transformation, and concern for bleeding at the access site.
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Post-Procedure
There should be a minimum 30 minutes delay before perioperative cleaning staff cleans the angiography suite to allow the
room to air out.7
In-room providers should wash their hands, sanitize, and
change out their scrubs or follow local protocol. Telephone
communication with the patient’s family should then be pursued as with any reperfusion therapy or procedure, but even
more so with the COVID-19 pandemic and restriction of
family/visitors.
Intubated patients should be extubated in a negative pressure room.
A definitive diagnosis of COVID-19 should be made as
soon as possible as patients who rule out will decrease the use
of protective equipment.7 Any tests that do not change management should be delayed or deferred (to protect staff, virus
trafficking, and conserve protective gear).7
Imaging of COVID-19 or suspected patients should be
limited to imaging that will impact management.17
When rounding, the usual sequence is by acuity of patient illness or geographic convenience. In the era of the
COVID-19 pandemic, assuming that all patients are equally
stable, patients on contact or droplet precaution should be
rounded on at the end of rounds to avoid unintentional viral
spread to patients not on precautions as clinical circumstances allow.
If a provider develops any symptoms of cough, fever, or
shortness of breath, they should seek testing and potential
quarantine based on local protocols.

Psychosocial Intervention
When appropriate, an evaluation of a patient’s mental health is
important to alleviate the psychosocial impact of the COVID19 epidemic for a patient in isolation with a new or recurrent
diagnosis of stroke.18
It is helpful to debrief with the team to learn, improve
best practices and workflow. Healthcare workers, particularly nurses and frontline healthcare workers directly engaged in the care of patients with COVID-19 are vulnerable
to the psychological burden of depression, anxiety, insomnia, and distress.19

Postacute Care
In preparation for the patient’s postacute care, testing for
COVID-19 may be required for a patient being discharged
to a postacute care facility, regardless of whether the patient
was being treated for COVID-19 at the hospital.20 Patients
who are asymptomatic or with minor signs of infection
have been shown capable of shedding potentially infectious
virus.21 Long- or short-term care facilities are vulnerable
to respiratory disease outbreaks, including the spread of
COVID-19.22 Early coordinated communication between the
primary team, case management, and postacute care facilities is important to reduce bottlenecks in patient transitions
once the patient is medically ready.

Conclusions
We live in uncharted times amidst the COVID-19 pandemic.
The word crisis in Chinese is composed of 2 characters, one
representing danger, the other opportunity. We cannot see this
dangerous enemy, the coronavirus. Every opportunity and detail to recalibrate our acute neurological workflow to protect
our frontline healthcare workers, our families, our colleagues,
and our patients should be sought, implemented, and adapted
to a resource-constrained environment. It is incumbent upon us
to protect each other so that we are not unknowingly exposed
or spread to our most vulnerable patients, while at the same
time, providing optimal care, patient safety, and access for our
patients with stroke. Optimizing protection of the healthcare
worker should not compromise emergency stroke patient care.
This guidance statement pertains to current practice and can
change as new evidence arises.
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